Hird, A. E., Magee, D. E., Cheung, D. C., Matta, R., Kulkarni, G. S., & Nam, R. K. (2020). Abiraterone vs. docetaxel for metastatic hormone-sensitive prostate cancer: A microsimulation model. Canadian Urological Association Journal, 14(9), E418–27. https://doi.org/10.5489/cuaj.6234